Altered coagulation profile in peripheral artery disease patients
Abdelrahman Zamzam(St. Michael's Hospital), Mohammad Qadura(University of Toronto), Shubha Jain(St. Michael's Hospital), Hamzah Khan(St. Michael's Hospital), Rawand Abdin(McMaster University), Muzammil H. Syed(St. Michael's Hospital), Subodh Verma(St. Michael's Hospital), Margaret L. Rand(University of Toronto), Mohamad A. Hussain(Brigham and Women's Hospital), Mohammed Al‐Omran(St. Michael's Hospital), Krishna K. Singh(Western University)
Cited by 22
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
New Markers of Inflammation and Endothelial Cell Activation
|Circulation|2003|733
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Endothelial cell control of thrombosis
|BMC Cardiovascular Disorders|2015|678